	US 12,441,762 B2
	Hepatitis c virus NS3/4A protease inhibitors
Celia A. Schiffer, Shrewsbury, MA (US); Akbar Ali, Westborough, MA (US); Jacqueto Zephyr, Worcester, MA (US); Ashley N. Matthew, Worcester, MA (US); and Nageswara R. Desaboini, Worcester, MA (US)
Assigned to University of Massachusetts, Westborough, MA (US)
Appl. No. 17/607,886
Filed by University of Massachusetts, Boston, MA (US)
PCT Filed Jun. 5, 2020, PCT No. PCT/US2020/036302 § 371(c)(1), (2) Date Oct. 31, 2021, PCT Pub. No. WO2020/247736, PCT Pub. Date Dec. 10, 2020.
Claims priority of provisional application 62/858,924, filed on Jun. 7, 2019.
Prior Publication US 2022/0227806 A1, Jul. 21, 2022
Int. Cl. C07K 5/083 (2006.01); A61K 38/00 (2006.01); C07K 5/107 (2006.01)

CPC C07K 5/0804 (2013.01) [C07K 5/1016 (2013.01); A61K 38/00 (2013.01)]

5 Claims

1. A compound having the structural formula (I_a),

OG Complex Work Unit Chemistry

wherein

R₁is R′;

R is a C₃-C₆cyclic alkyl group; and

R′ is a C₁-C₃alkyl.